News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
877,156 Results
Type
Article (88419)
Company Profile (813)
Press Release (787894)
Multimedia
Podcasts (220)
Webinars (34)
Section
Business (233434)
Career Advice (4155)
Deals (39924)
Drug Delivery (168)
Drug Development (91557)
Employer Resources (207)
FDA (18486)
Job Trends (17459)
News (398360)
Policy (40006)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (3037)
Academic (2)
Accelerated approval (46)
Adcomms (37)
Allergies (175)
Alliances (56985)
ALS (209)
Alzheimer's disease (1899)
Antibody-drug conjugate (ADC) (433)
Approvals (18730)
Artificial intelligence (755)
Autoimmune disease (257)
Automation (55)
Bankruptcy (407)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (223)
Biotechnology (486)
Bladder cancer (187)
Brain cancer (75)
Breast cancer (737)
Cancer (5776)
Cardiovascular disease (512)
Career advice (3584)
Career pathing (47)
CAR-T (337)
CDC (72)
Celiac Disease (2)
Cell therapy (929)
Cervical cancer (45)
Clinical research (77979)
Collaboration (2142)
Company closure (7)
Compensation (1338)
Complete response letters (96)
COVID-19 (3018)
CRISPR (111)
C-suite (1088)
Cystic fibrosis (161)
Data (7372)
Decentralized trials (3)
Denatured (82)
Depression (179)
Dermatology (67)
Diabetes (598)
Diagnostics (7426)
Digital health (59)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (378)
Drug pricing (239)
Drug shortages (39)
Duchenne muscular dystrophy (287)
Earnings (101364)
Editorial (72)
Employer branding (25)
Employer resources (174)
Events (136666)
Executive appointments (1121)
FDA (22126)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (33)
Funding (1769)
Gene editing (240)
Generative AI (84)
Gene therapy (760)
GLP-1 (1217)
Government (5516)
Grass and pollen (8)
Guidances (404)
Healthcare (21048)
HIV (82)
Huntington's disease (58)
IgA nephropathy (98)
Immunology and inflammation (330)
Immuno-oncology (96)
Indications (164)
Infectious disease (3375)
Inflammatory bowel disease (224)
Inflation Reduction Act (17)
Influenza (141)
Intellectual property (287)
Interviews (817)
IPO (17977)
IRA (61)
Job creations (5205)
Job search strategy (2869)
JPM (73)
Kidney cancer (20)
Labor market (106)
Layoffs (671)
Leadership (46)
Legal (10169)
Liver cancer (106)
Longevity (30)
Lung cancer (767)
Lymphoma (421)
Machine learning (57)
Management (66)
Manufacturing (1048)
MASH (196)
Medical device (15167)
Medtech (15253)
Mergers & acquisitions (23137)
Metabolic disorders (1613)
mRNA (218)
Multiple sclerosis (186)
NASH (24)
Neurodegenerative disease (440)
Neuropsychiatric disorders (117)
Neuroscience (3456)
Neurotech (2)
NextGen: Class of 2026 (7713)
Non-profit (5131)
Now hiring (75)
Obesity (787)
Opinion (359)
Ovarian cancer (202)
Pain (255)
Pancreatic cancer (276)
Parkinson's disease (373)
Partnered (39)
Patents (594)
Patient recruitment (643)
Peanut (65)
People (67482)
Pharmaceutical (138)
Pharmacy benefit managers (36)
Phase 1 (24086)
Phase 2 (33855)
Phase 3 (25478)
Pipeline (7579)
Policy (374)
Postmarket research (3555)
Preclinical (10802)
Press Release (72)
Prostate cancer (295)
Psychedelics (61)
Radiopharmaceuticals (336)
Rare diseases (1129)
Real estate (7448)
Recruiting (81)
Regulatory (29747)
Reports (74)
Research institute (2756)
Resumes & cover letters (653)
Rett syndrome (34)
RNA editing (23)
RSV (96)
Schizophrenia (181)
Series A (294)
Series B (219)
Service/supplier (30)
Sickle cell disease (115)
Special edition (29)
Spinal muscular atrophy (186)
Sponsored (52)
Startups (4350)
State (2)
Stomach cancer (21)
Supply chain (139)
Tariffs (104)
The Weekly (135)
Vaccines (1238)
Venture capital (111)
Weight loss (539)
Women's health (120)
Worklife (23)
Date
Today (150)
Last 7 days (571)
Last 30 days (2740)
Last 365 days (32892)
2026 (9486)
2025 (33227)
2024 (38126)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1293)
Alabama (100)
Alaska (7)
Arizona (372)
Arkansas (16)
Asia (51918)
Australia (9122)
California (12937)
Canada (3672)
China (1357)
Colorado (558)
Connecticut (567)
Delaware (392)
Europe (119549)
Florida (1937)
Georgia (424)
Hawaii (4)
Idaho (69)
Illinois (1105)
India (92)
Indiana (609)
Iowa (24)
Japan (520)
Kansas (138)
Kentucky (52)
Louisiana (44)
Maine (87)
Maryland (1595)
Massachusetts (9478)
Michigan (394)
Minnesota (735)
Mississippi (7)
Missouri (156)
Montana (37)
Nebraska (30)
Nevada (144)
New Hampshire (90)
New Jersey (3482)
New Mexico (33)
New York (3432)
North Carolina (1768)
North Dakota (10)
Northern California (6312)
Ohio (402)
Oklahoma (26)
Oregon (54)
Pennsylvania (2589)
Puerto Rico (29)
Rhode Island (53)
South America (1668)
South Carolina (83)
South Dakota (2)
Southern California (5048)
Tennessee (206)
Texas (2087)
United States (46607)
Utah (390)
Vermont (1)
Virginia (330)
Washington D.C. (88)
Washington State (1070)
West Virginia (4)
Wisconsin (144)
Wyoming (2)
There are 877,156 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cardiol Therapeutics to Highlight MAVERIC Phase III Trial and Recently Published ARCHER Results in Live Interview with Barchart
April 14, 2026
·
4 min read
Press Releases
BioMark Diagnostics to Present Liquid Biopsy Platform at the Canadian Thoracic Society Research Forum
BioMark Comprehensive Metabolomics Assay Selected as Top Canadian Innovation for the CTS Beaver Den Innovation Award
April 14, 2026
·
4 min read
Press Releases
Kiora’s Phase 1 ABACUS Study of KIO-301 in Retinitis Pigmentosa Published in Nature Medicine; Phase 2 Trial Underway
April 14, 2026
·
6 min read
Press Releases
Telo Genomics Announces Study with University of Athens to Advance Next-Generation MRD Risk Stratification in Multiple Myeloma
Clinical Trial Seeks to Validate Novel Blood-Based Assay that Predicts Relapse Risk by Analyzing the Biologic Behavior of Remaining Cancer Cells, Addressing Critical Gaps in Current Minimal Residual Disease (MRD) Testing
April 14, 2026
·
6 min read
Press Releases
Healthcare Contract Research Organization Market to Reach Around USD 124.56 Billion by 2035
April 14, 2026
·
1 min read
Press Releases
Pharmaceutical CRO & CDMO Market Forecast from USD 254.65 Bn to USD 594.07 Bn by 2035
April 14, 2026
·
1 min read
Press Releases
Vetter Strengthens its Global Clinical Manufacturing Network with Strategic Site Enhancements
Further advancements in Europe and the US increase capacity and process efficiency ● Construction of new clinical manufacturing facility in Des Plaines on schedule ● Established Skokie site with ongoing strong performance for biotech partners ● Infrastructure upgrades at Austrian site further streamline customers’ path to clinic
April 14, 2026
·
1 min read
Gene editing
FDA bolsters bespoke therapy framework with new draft safety guidelines
The draft guidance supports the agency’s new pathway designed to speed up the development of custom gene therapies.
April 14, 2026
·
2 min read
·
Gabrielle Masson
Cytiva
Cytiva, now with the life sciences business from Pall Corporation, is a global biotechnology leader dedicated to helping customers discover and commercialize the next generation of therapeutics. We bring dedicated technical expertise and a broad portfolio of tools, technologies, and services that enable the development, manufacture, and delivery of transformative medicines to patients. We’re the provider of leading life science brands such as ÄKTA, Amersham, HyClone, MabSelect and Whatman.
Press Releases
Phrontline Biopharma Presents Preclinical Data for TJ106, a Biparatopic HER2 Dual-Payload ADC, at American Association for Cancer Research Annual Meeting 2026
April 14, 2026
·
3 min read
1 of 87,716
Next
